Nigel McCracken
Chief Operating Officer bei VIRAX BIOLABS GROUP LIMITED
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Nelson Haight | M | 59 | - | |
| Evan Norton | M | 49 | - | |
| Martin Olin | M | 55 | 3 Jahre | |
| James Foster | M | 37 | 11 Jahre | |
| Mark Ternouth | M | 56 | - | |
| Yair Erez | M | 50 | - | |
| Pierre Jullian | M | - |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 6 Jahre |
| Gayle Mills | F | 69 | 3 Jahre | |
| Jason Davis | M | 52 | 2 Jahre | |
| Cristina Oliva | M | - | 2 Jahre | |
| Anders Lennart Tullgren | M | 63 | 2 Jahre | |
| Tomasz George | M | 40 | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Cameron Shaw | M | 37 | 10 Jahre | |
| James Bradley Lorens | M | - | 14 Jahre | |
| Richard Stuart Godfrey | M | 58 | 13 Jahre | |
| Stener Kvinnsland | M | 76 | 7 Jahre | |
| Hani Gabra | M | - | 3 Jahre | |
| E. Gwyn Thomas | M | - | 1 Jahre | |
| Andres McAllister | M | 68 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 11 Jahre |
| Alison Messom | M | 52 | 2 Jahre | |
| Christine Deuschel Cornioley | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 23 Jahre |
| Debbie Molyneux | F | - | 4 Jahre | |
| Gro Gausdal | M | - | 8 Jahre | |
| Chris Freitag | M | 58 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Norwegen | 12 | 50,00% |
| Vereinigtes Königreich | 8 | 33,33% |
| Schweiz | 4 | 16,67% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Nigel McCracken
- Persönliches Netzwerk
